Favourable Review For Misonix BoneScalpel™ In New Spine Paper

The Misonix BoneScalpel has seen favourable reviews in new clinical paper accepted for publication by “Neurosurgery,”. In the study the device was used to perform safe, tissue-selective bone dissection that encourages en-bloc bone removal and refined osteotomies while sparing elastic soft tissue structures.

Misonix BoneScalpel™ Subject of New Clinical Paper Focused on Spine Surgery (via PR Newswire)

FARMINGDALE, N.Y., March 26, 2013 /PRNewswire/ — Misonix, Inc. (NasdaqGM: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic…

published: March 27, 2013 in: Clinical Studies/Trials, Spine

Most read

Latest

^